Skip to main content
Past Event

Promoting Biomedical Innovation and Economic Value: New Models for Reimbursement and Evidence Development

A central goal of health care reform is to provide more effective, personalized care at a lower cost. Medical breakthroughs enabled by modern science are key to achieving this goal. To ensure that Americans continue to benefit from these breakthroughs, we must take steps now to foster a culture of biomedical innovation. Simultaneously, to ensure that these breakthroughs are accessible and affordable for all who need them, we need to adopt policies that promote economic value in the delivery of health care.

On April 22, the Engelberg Center for Health Care Reform and the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California hosted an event with key stakeholders to discuss practical steps in reimbursement and evidence development that can promote such innovation and economic value. Former House Speaker Newt Gingrich and former Office of Management and Budget Director Peter Orszag offered keynote remarks.


Watch the archived event on C-SPAN »

Agenda

Welcome

Mark B. McClellan

Former Brookings Expert

Director, Margolis Center for Health Policy - Duke University

Opening Keynote Address

Newt Gingrich

Center for Health Transformation

Speaker of the House of Representatives during the welfare reform debate

Panel I: Impact of Different Reimbursement Systems on Innovation

Panel II: Opportunities to Drive Innovation with New Payment Policies

Panel III: Issues in Measuring Innovation and Value

Mark B. McClellan

Former Brookings Expert

Director, Margolis Center for Health Policy - Duke University

Closing Keynote Address

Peter R. Orszag

Vice Chairman of Investment Banking, Managing Director, and Global Co-Head of Healthcare - Lazard

More Information

To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.

Get a weekly events calendar from Brookings